Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 94 publications
RNA interference medication and transplantation procedures in patients with primary hyperoxaluria type 1 (PH1).
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: October 03, 2025
Long-term Lumasiran Therapy Final Results from a Phase 2 Open-label Extension Study in Primary Hyperoxaluria.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: September 22, 2025
Administration of lumasiran in a child with infantile oxalosis undergoing chronic peritoneal dialysis: A case report
Journal: Nephrologie & therapeutique
Published: June 11, 2025
Fine-tuning circulating oxalate levels to improve transplant strategies in primary hyperoxaluria: what is the ideal threshold in pediatrics?
Journal: Nephrologie & therapeutique
Published: March 11, 2025
Primary hyperoxaluria type 1 - an unexpected diagnosis after kidney transplantation.
Journal: Kidney & blood pressure research
Published: March 09, 2025
The evolving role of liver transplantation as enzyme replacement therapy in the era of RNA nanotherapies.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: March 06, 2025
Plasma Glycolate Levels Contribute to Drive the Decision of Isolated Kidney Transplantation in Dialyzed Patients with End-Stage Kidney Disease due to Primary Hyperoxaluria Type 1 Treated with Lumasiran: A Case Report.
Journal: Case reports in nephrology and dialysis
Published: February 04, 2025
Development, opportunities, and challenges of siRNA nucleic acid drugs.
Journal: Molecular therapy. Nucleic acids
Published: February 03, 2025
Lumasiran at birth changes the trajectory of primary hyperoxaluria type 1: same disease, different outcomes in two affected siblings.
Journal: Journal of nephrology
Published: January 17, 2025
Controlled access to lumasiran in primary hyperoxaluria type 1: evaluation of a new access route for orphan drugs in the Netherlands.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: January 09, 2025
Hidden in CAKUT: Post-Transplant Diagnosis of Primary Hyperoxaluria Type 1 and Rescue Management Using Lumasiran.
Journal: Pediatric transplantation
Published: December 10, 2024
Concomitant Treatment With Lumasiran and Nedosiran in a Child With Primary Hyperoxaluria Type 1.
Journal: Kidney international reports
Published: December 02, 2024
Last Updated: 10/31/2025